HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Increased exposure likely driving ‘epidemic’ of HPV-associated cancers
-
- ALK-targeted therapeutics represent ‘profound revolution’ in personalized cancer therapy Patrick C. Ma, MD, MSc
- Breast care center hires new director
- Clinician receives professorship
- MAGELLAN: Extended-duration rivaroxaban reduced VTE risk
- Penn, CHOP to open blood disease center
- Researcher joins Cedars-Sinai
- Researcher joins Sloan-Kettering
- FDA grants ‘breakthrough’ designation for NSCLC therapy
-
- A 78-year-old female with diplopia and ptosis Munir Ghesani, MD, FACNM; Mina Samir Erian Hanna, MD; Michael L. Grossbard, MD; Rahul Parikh, MD; Sagar Patel, MD
- Therapy-related AML risk varied over time
- Smoking relapse more common in patients who smoked before surgery Michael B. Steinberg, MD, MPH, FACP
- Incidence of advanced breast cancer increased among younger women
- Risk for lung cancer mortality surges for women smokers
- Addition of rituximab to chlorambucil failed to improve OS in MALT lymphoma
- Alternative screening methods may reduce mortality in prostate cancer
- Cancer deaths, life expectancy both on the rise worldwide
-
- Copper depletion agent reduced breast cancer relapse
- Nilotinib associated with fewer BCR-ABL mutations in chronic phase CML
- R-BAC shows promise in mantle cell lymphoma
- Sorafenib shows promise for patients with advanced soft tissue sarcomas
- Trial of elesclomol/paclitaxel in melanoma terminated
- Intraperitoneal chemotherapy improved ovarian cancer survival
- HD IL-2 should be considered for patients with melanoma brain metastases
- Most patients with ovarian cancer fail to receive recommended treatment
-
- Biochemotherapy offers potential alternative to interferon for high-risk melanoma
- RED HF: Darbepoetin alfa failed to improve systolic HF, anemia
- Bereavement and grief: What every oncologist should know
- Memantine may help prevent cognitive decline after brain radiation Lisa K. Lohr, PharmD, BCPS, BCOP